Salarius Pharmaceuticals (SLRX) Institutional Ownership $1.44 +0.04 (+2.86%) (As of 11/21/2024 ET) Add Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Salarius Pharmaceuticals (NASDAQ:SLRX)CurrentInstitutional OwnershipPercentage11.88%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$858.18K Get SLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Salarius Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLRX Institutional Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Salarius Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC22,750$54K0.0%-72.9%3.811% 2/13/2024 Armistice Capital LLC88,000$57K0.0%-60.9%2.234% 11/15/2023 Armistice Capital LLC225,000$148K0.0%+105.2%5.711% 11/15/2021 HighTower Advisors LLC26,000$26K0.0%N/A0.058% 11/9/2021BlackRock Inc.116,309$119K0.0%-13.7%0.260% 8/25/2021 Marshall Wace LLP174,474$185K0.0%+29.6%0.390% Get the Latest News and Ratings for SLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/17/2021 X Square Capital LLC100,458$106K0.1%-39.4%0.224% 8/16/2021 Maven Securities LTD1,316,205$1.37M0.1%-31.7%2.939% 8/16/2021 State Street Corp142,552$151K0.0%N/A0.318% 8/16/2021 Sabby Management LLC249,033$264K0.0%-6.7%0.556% 8/16/2021 Marshall Wace LLP174,474$185K0.0%+29.6%0.390% 8/13/2021 Northern Trust Corp65,022$69K0.0%+25.9%0.145% 8/13/2021 Geode Capital Management LLC277,035$293K0.0%+124.4%0.619% 8/13/2021 Vanguard Group Inc.1,544,724$1.64M0.0%+8.7%3.450% 8/12/2021 Dimensional Fund Advisors LP36,634$39K0.0%-40.8%0.082% 5/19/2021 Worth Venture Partners LLC424,800$629K0.3%+17.8%0.949% 5/18/2021 Millennium Management LLC28,675$42K0.0%+40.5%0.064% 5/18/2021 Silverarc Capital Management LLC1,992,181$2.95M1.6%N/A4.450% 5/14/2021 Dimensional Fund Advisors LP61,839$92K0.0%N/A0.138% 5/13/2021 Renaissance Technologies LLC237,601$352K0.0%N/A0.531% 5/13/2021 Kepos Capital LP548,054$811K0.1%+338.4%1.225% 5/13/2021 X Square Capital LLC165,708$245K0.1%+186.4%0.370% 5/12/2021 Northern Trust Corp51,648$76K0.0%+248.6%0.115% 5/12/2021 Geode Capital Management LLC123,461$182K0.0%+573.5%0.276% 5/12/2021Granite Point Capital Management L.P.1,563,561$2.31M0.1%N/A3.495% 5/6/2021 Meitav Dash Investments Ltd.52,000$77K0.0%N/A0.116% 5/6/2021 Altium Capital Management LP1,250,110$1.85M0.5%N/A2.795% 3/26/2021 Susquehanna International Group LLP33,320$30K0.0%N/A0.074% 2/17/2021 Worth Venture Partners LLC360,556$328K0.3%+39.6%1.514% 2/16/2021 Squarepoint Ops LLC101,682$93K0.0%+765.5%0.427% (Data available from 1/1/2016 forward) SLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Salarius Pharmaceuticals shares: Armistice Capital LLC ($54K).Learn more on SLRX's institutional investors. What percentage of Salarius Pharmaceuticals stock is owned by institutional investors? 11.88% of Salarius Pharmaceuticals stock is owned by institutional investors. Learn more on SLRX's institutional investor holdings. Which institutional investors have been buying Salarius Pharmaceuticals stock? The following institutional investors have purchased Salarius Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($115.36K). How much institutional buying is happening at Salarius Pharmaceuticals? Institutional investors have bought a total of 115,364 shares in the last 24 months. This purchase volume represents approximately $607.18K in transactions. Which Salarius Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Salarius Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($198.25K). How much institutional selling is happening at Salarius Pharmaceuticals? Institutional investors have sold a total of 198,250 shares in the last 24 months. This volume of shares sold represents approximately $858.18K in transactions. This page (NASDAQ:SLRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Salarius Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Salarius Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLRX Stock Alerts